Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery PD-L1
Path
Created with Sketch.
Go to PD-L1 Normal Tissue Gallery
Go back to Product Page
Breast - Breast cancer NST with PD-L1 negative tumor cells but intense PD-L1 staining in tumor associated inflammatory cells.
Breast – Breast cancer NST with PD-L1 negative tumor cells but intense PD-L1 staining in tumor associated inflammatory cells.
Breast - Breast cancer NST with PD-L1 negative tumor cells. Tumor associated inflammatory cells show strongest PD-L1 staining if they are immediately adjacent to tumor cells.
Breast – Breast cancer NST with PD-L1 negative tumor cells. Tumor associated inflammatory cells show strongest PD-L1 staining if they are immediately adjacent to tumor cells.
Colon - Colorectal adenocarcinoma with moderate to strong membranous PD-L1 staining in the vast majority of its tumor cells.
Colon – Colorectal adenocarcinoma with moderate to strong membranous PD-L1 staining in the vast majority of its tumor cells.
Colon - Colorectal adenocarcinoma with PD-L1 negative tumor cells surrounded by large numbers of tumor associated inflammatory cells with intense PD-L1 staining.
Colon – Colorectal adenocarcinoma with PD-L1 negative tumor cells surrounded by large numbers of tumor associated inflammatory cells with intense PD-L1 staining.
Colon - Colorectal adenocarcinoma with PD-L1 staining limited to intraglandular macrophages.
Colon – Colorectal adenocarcinoma with PD-L1 staining limited to intraglandular macrophages.
Kidney - Weak to moderate membranous PD-L1 staining in a clear cell renal cell carcinoma.
Kidney – Weak to moderate membranous PD-L1 staining in a clear cell renal cell carcinoma.
Lymph node - Strong PD-L1 immunostaining in all tumor cells of an anaplastic large cell lymphoma.
Lymph node – Strong PD-L1 immunostaining in all tumor cells of an anaplastic large cell lymphoma.
Ovary - Few scattered PD-L1 positive cells in a mucinous ovarian cancer. Most likely, these cells are tumor associated macrophages.
Ovary – Few scattered PD-L1 positive cells in a mucinous ovarian cancer. Most likely, these cells are tumor associated macrophages.
Prostate - Few scattered cells (tumor cells or tumor associated macrophages) with membranous PD-L1 staining in a recurrent Gleason 5+5 adenocarcinoma of the prostate.
Prostate – Few scattered cells (tumor cells or tumor associated macrophages) with membranous PD-L1 staining in a recurrent Gleason 5+5 adenocarcinoma of the prostate.
Prostate - Moderate to strong membranous PD-L1 staining in virtually all tumor cells of a Gleason 5+5 prostate cancer.
Prostate – Moderate to strong membranous PD-L1 staining in virtually all tumor cells of a Gleason 5+5 prostate cancer.
Skin - Strong focal PD-L1 staining in tumor associated inflammatory cells in a basal cell carcinoma of the skin. PD-L1 staining is not seen in tumor cells.
Skin – Strong focal PD-L1 staining in tumor associated inflammatory cells in a basal cell carcinoma of the skin. PD-L1 staining is not seen in tumor cells.
Stomach - Strong PD-L1 positivity in all tumor cells of a gastrointestinal stromal tumor (GIST).
Stomach – Strong PD-L1 positivity in all tumor cells of a gastrointestinal stromal tumor (GIST).
Thyroid - Follicular thyroid cancer with moderate to strong membranous PD-L1 staining.
Thyroid – Follicular thyroid cancer with moderate to strong membranous PD-L1 staining.
Urinary bladder - Non-invasive papillary urothelial carcinoma with moderate PD-L1 staining which is strictly limited to the basal cell layer. Absence of tumor associated inflammatory cells.
Urinary bladder – Non-invasive papillary urothelial carcinoma with moderate PD-L1 staining which is strictly limited to the basal cell layer. Absence of tumor associated inflammatory cells.
Urinary bladder - Urothelial carcinoma with PD-L1 negative tumor cells containing large numbers of PD-L1 positive tumor associated inflammatory cells.
Urinary bladder – Urothelial carcinoma with PD-L1 negative tumor cells containing large numbers of PD-L1 positive tumor associated inflammatory cells.
Urinary bladder - Urothelial carcinoma with prominent PD-L1 staining in tumor associated inflammatory cells. In addition, few tumor cells show faint membranous staining.
Urinary bladder – Urothelial carcinoma with prominent PD-L1 staining in tumor associated inflammatory cells. In addition, few tumor cells show faint membranous staining.
Vulva - Weak to moderate membranous PD-L1 positivity in the majority of tumor cells of a squamous cell carcinoma of the vulva.
Vulva – Weak to moderate membranous PD-L1 positivity in the majority of tumor cells of a squamous cell carcinoma of the vulva.